(TSX:GTE),(NYSE MKT:GTE),(LSE:GTE), CALGARY, Alberta, Oct. 24, 2025 (GLOBE NEWSWIRE) — Gran Tierra Energy Inc. (“Gran Tierra” or the “Company“) (NYSE American:GTE)(TSX:GTE)(LSE:GTE) today announced that it has, through its wholly owned subsidiary Gran Tierra Energy Colombia GmbH, a Swiss limited liability company (the “Seller“), entered into a crude oil sale and purchase agreement and a related […]

(NasdaqGM:FGNX),(NasdaqGM:FGNXP), Charlotte, NC, Oct. 24, 2025 (GLOBE NEWSWIRE) — FG Nexus (Nasdaq: FGNX, FGNXP) (the “Company”), today announced that the Company's common stock is now available for options trading on the NYSE Arca Options and NYSE American Options, which are distinct but integrated options exchanges operated by the New York Stock Exchange. FG Nexus options

(NYSE MKT:INDO), MOU furthers IEC's efforts with Aquila Energia to explore the promotion of sustainable off grid energy solutions for the growing digital economy in Brazil JAKARTA, INDONESIA AND DANVILLE, CA, Oct. 24, 2025 (GLOBE NEWSWIRE) — Indonesia Energy Corporation (NYSE American: INDO) (“IEC”), an oil and gas exploration and production company focused on energy

(NASDAQ:BIIB), The oral C5aR1 antagonist is designed to modulate neutrophil-driven inflammation, a central mechanism underlying many inflammatory diseases CAMBRIDGE, Mass. and CHICAGO, Oct. 24, 2025 (GLOBE NEWSWIRE) — Biogen Inc. (Nasdaq: BIIB) and Vanqua Bio today announced a license agreement granting Biogen exclusive worldwide rights to Vanqua's preclinical, oral C5aR1 antagonist. This agreement strengthens Biogen's

(TSX:AGF-B),(TSX:AGF.B),(TSX:AGFB),(Neo:AENU.NE),(Neo:ATRB.NE),(Neo:QIF.NE), TORONTO, Oct. 24, 2025 (GLOBE NEWSWIRE) — AGF Investments Inc. (AGF Investments) today announced the October 2025 cash distributions for AGF Enhanced U.S. Equity Income Fund*, AGF Total Return Bond Fund* and AGF Systematic Global Infrastructure ETF, which pay monthly distributions. Unitholders of record on October 31, 2025 will receive cash distributions payable on

Biogen Licenses Oral C5aR1 Antagonist from Vanqua Bio to Expand Immunology Portfolio GlobeNewswire October 24, 2025 The oral C5aR1 antagonist is designed to modulate neutrophil-driven inflammation, a central mechanism underlying many inflammatory diseases CAMBRIDGE, Mass. and CHICAGO, Oct. 24, 2025 (GLOBE NEWSWIRE) — Biogen Inc. (Nasdaq: BIIB) and Vanqua Bio today announced a license agreement

ChoiceOne Financial Services, Inc. (“ChoiceOne”, NASDAQ:COFS), the parent company for ChoiceOne Bank, reported financial results for the quarter ended September 30, 2025. https://mma.prnewswire.com/media/1169029/ChoiceOne_Financial_Services_Logo.jpg Significant items impacting comparable first nine month period of 2024 and 2025 results include the following: — On March 1, 2025, ChoiceOne completed the merger (the “Merger”) of Fentura Financial, Inc. (“Fentura”),

BMO Asset Management Inc. (“BMOAM Inc.”), the manager of the BMO ETFs,today announced the launch of BMO Broad Commodity ETF (the “BMO ETF”).This new BMO ETF provides a transparent and efficient way to diversify a portfolio without trading individual commodities. “The BMO Broad Commodity ETF reduces complexity, giving investors streamlined access to global commodity markets

NEW YORK, NY / ACCESS Newswire / October 24, 2025 / If you suffered a loss on your aTyr Pharma, Inc. (NASDAQ:ATYR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/atyr-pharma-inc-lawsuit-submission-form?prid=173776&wire=1&utm_campaign=6 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

AGF Investments Announces October 2025 Cash Distributions for AGF Enhanced U.S. Equity Income Fund, AGF Total Return Bond Fund and AGF Systematic Global Infrastructure ETF GlobeNewswire October 24, 2025 TORONTO, Oct. 24, 2025 (GLOBE NEWSWIRE) — AGF Investments Inc. (AGF Investments) today announced the October 2025 cash distributions for AGF Enhanced U.S. Equity Income Fund*,